Table 2 Treatment outcomes for patients treated with Artemether-Lumefantrine

Initially selected

122

28 ≤ 5 years

94 > 5 years

Number of patients: n

 PCR uncorrected responses

  Withdrawn + Lost, n (%)

19 (15.6)

7 (25)

12 (12.8)

  Eligible; n (%)

103 (100)

21 (20.4)

82 (79.6)

  Global failure; n (%)

10 (9.7)

5 (23.8)

5 (6.1)

  ETF; n (%)

1 (1 %)

1 (4.8)

0

  LCF; n (%)

1 (1)

0

1 (1.2)

  LPF; n (%)

8 (7.8)

4 (19)

4 (4.9)

  ACPR; n (%)

93 (90.3)

16 (76.2)

77 (94)

 PCR corrected responses

  Eligible; n (%)

103 (100)

21 (20.4)

82 (78.6)

  Global Failure; n (%)

9 (8.7)

5 (24)

4 (5)

  ACPR; n (%)

94 (91.2)

16 (76)

78 (95)

  Recrudescence; n (%)

2 (1.9)

1 (4.8)

1 (1.2)

  Reinfection; n (%)

1 (1)

0

1 (1.2)